CEO, American Cancer Society and American Cancer Society Cancer Action Network
If this is going to help solve for gathering all the needed information for pre-auth, that will be a win for everyone, not just the patients, but also the clinical teams. #EveryCancerEveryLife
I'm thrilled to share news about the Color Copilot, which we developed in partnership with OpenAI. WSJ exclusive: https://lnkd.in/gu3k67Gc OpenAI's post: https://lnkd.in/gf7DbRqv Color’s blog post: https://lnkd.in/ga4Q635h Through our work with 7mm patients & American Cancer Society, we've seen the impact of access firsthand. Simply put: Healthcare being available doesn’t make it accessible. Making services and information accessible at the right time often outweighs anything else we can do. Our bet is that the GenAI revolution is the biggest opportunity to improve access and immediacy to critical health information & services. Rather than going broad, we started by going deep scaling the ability of clinicians to support a few specific, but highly impactful use cases/scenarios that are constrained by access to experts. Read all about our work through the links above and reach out to us at copilot@color.com if you take care of cancer patients or are interested in the space and would like to find out more!
Clinial Research Assistant at University of Connecticut Health Center
1moUniversal Access to drive prospects to best, liquid biopsy for early interception of cancer is how AI can really help. Stage shift will happen & will matter.